序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(03-31)
|
归母净利润同比增长(12-31)
|
营业收入同比增长(03-31)
|
营业收入同比增长(12-31)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 17.22 | 25.27 | 24.72 | 1.82 | 1.73% | 153.16 | 5.68% | -41.34% | 0.98% | -6.57% |
2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 23.66 | — | — | 2.48 | — | 129.06 | 95.48% | -207.83% | 18.21% | -17.87% |
3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 47.32 | 36.88 | 46.6 | 2.11 | 0.74% | 31.55 | -60.09% | -20.87% | -21.20% | 10.91% |
4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 8.11 | 75.14 | 75.03 | 3.99 | — | 31.17 | 0.28% | 219.75% | 6.65% | 4.46% |
5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 11.5 | — | — | 4.69 | — | 57.27 | 126.09% | 75.30% | 11.37% | -14.77% |
6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 7.94 | — | — | 3.18 | — | 51.53 | -41.04% | -151.54% | -11.29% | 21.16% |
7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 48.31 | — | — | 2.07 | — | 52.77 | -152.59% | -119.39% | -40.32% | -21.18% |
8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 27.05 | — | — | 1.98 | 0.72% | 41.85 | -107.51% | -130.89% | -24.37% | -19.59% |
9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 55.54 | 38.25 | 37.45 | 2.9 | 0.29% | 53.64 | 13.12% | -13.73% | -2.53% | 3.14% |
10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 38.05 | 118.7 | 66.15 | 2.13 | 1.05% | 45.83 | 183.24% | -77.76% | 41.83% | -35.19% |
11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 62.0 | 131.76 | 159.1 | 2.66 | 0.48% | 533.84 | -29.61% | -79.99% | -5.79% | -10.58% |
12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 42.06 | 40.13 | 61.61 | 2.52 | — | 59.30 | -90.33% | -24.00% | -29.35% | 9.94% |
13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 64.8 | — | — | 4.1 | — | 87.06 | 61.27% | -896.21% | 2.92% | -24.01% |
14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 37.19 | 446.38 | 157.36 | 1.72 | — | 28.99 | 92.50% | 131.56% | 6.59% | 4.01% |
15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 114.48 | 43.5 | 41.55 | 2.46 | 0.96% | 412.81 | 15.83% | -58.17% | 10.10% | -25.82% |
16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 58.4 | 61.29 | 49.98 | 4.37 | — | 123.55 | 272.28% | 58.17% | 20.05% | 20.75% |
17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 30.0 | 29.75 | 28.55 | 3.9 | 0.67% | 533.46 | 32.54% | 12.01% | 16.03% | 6.39% |
18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 16.09 | 60.07 | 59.8 | 3.12 | — | 65.97 | 1.70% | -30.89% | 8.76% | 10.39% |
19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 10.52 | 140.57 | 250.26 | 4.09 | 0.11% | 40.45 | -76.38% | 18.23% | -17.06% | 33.50% |
20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 46.43 | — | — | 2.56 | 0.28% | 60.77 | 15.81% | 42.60% | 18.79% | 7.75% |
21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | 55.37 | 34.96 | 46.2 | 6.13 | — | 62.01 | -59.34% | -3.98% | -8.49% | 15.70% |
22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 44.42 | 40.41 | 43.1 | 3.12 | 0.63% | 88.72 | -27.67% | 11.24% | 20.55% | -2.12% |
23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 41.16 | 30.55 | 35.69 | 2.79 | 0.61% | 32.52 | -67.32% | -21.01% | -4.37% | 5.75% |
24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 58.98 | 45.65 | 43.92 | 2.74 | — | 53.60 | 17.71% | 7.17% | 12.83% | 0.93% |
25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 38.31 | 313.03 | 210.62 | 5.34 | 1.11% | 53.48 | 226.47% | -54.59% | 29.61% | 11.18% |
26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 29.9 | 302.52 | 57.84 | 2.76 | 0.53% | 224.09 | 115.11% | -81.34% | -11.54% | -15.07% |
27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 88.88 | 27.01 | 22.83 | 4.36 | 1.51% | 2552.83 | 89.06% | -1.63% | 20.96% | -2.73% |
28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 22.85 | 178.27 | 139.35 | 6.54 | — | 91.56 | 102.90% | 26.13% | -0.60% | 14.99% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。